News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
12 Results
12 Results
RECOVER-AUTONOMIC clinical trial results shared at 2026 ACC Conference
The RECOVER-AUTONOMIC (Ivabradine) clinical trial tested whether ivabradine, an oral medication used to lower heart rate, could be used to manage a Long COVID symptom called postural orthostatic tachycardia syndrome (POTS).
Announcement
RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will share insights and answer questions about the progress being made on the first wave of RECOVER-TLC clinical trials.
Announcement
RECOVER-TLC opens expanded enrollment in REVERSE-LC clinical trial
Researchers at 17 study sites across the US will test a possible treatment to help improve thinking and memory problems and reduce fatigue for people who have Long COVID.
Announcement
First results from RECOVER-AUTONOMIC clinical trials to be shared at upcoming conference
Results from the RECOVER-AUTONOMIC Moderate POTS (Ivabradine) clinical trial will be presented at an upcoming session of the American College of Cardiology (ACC) Annual Conference on March 28, 2026.
Announcement
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
RECOVER-TLC to hold next webinar January 23, 2026
On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
Announcement
RECOVER-TLC invites public comments on upcoming clinical trials
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Announcement
Registration open for second annual RECOVER-TLC workshop, September 9-10
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Announcement